These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12218399)

  • 21. Correlation of baseline quantitative plasma human immunodeficiency (HIV) type 1 RNA viral load with clinical status and CD4+ T-cell counts in treatment-naïve HIV-positive patients in Singapore.
    Ho BC; Laudette-Aboulhab J; Se-Thoe SY; Chan SP; Ling AE; Leo YS
    Ann Acad Med Singap; 2000 Nov; 29(6):708-13. PubMed ID: 11269974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of Genetically Determined Continental Ancestry With CD4+ Count and Plasma HIV-1 RNA Beyond Self-Reported Race and Ethnicity.
    Brummel SS; Singh KK; Maihofer AX; Farhad M; Qin M; Fenton T; Nievergelt CM; Spector SA
    J Acquir Immune Defic Syndr; 2016 Apr; 71(5):544-50. PubMed ID: 26536313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health literacy and current CD4 cell count in a multiethnic U.S. sample of adults living with HIV infection.
    Walker RL; Hong JH; Talavera DC; Verduzco M; Woods SP
    Int J STD AIDS; 2018 Apr; 29(5):498-504. PubMed ID: 29065780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents. Adolescent Medicine HIV/AIDS Research Network.
    Holland CA; Ellenberg JH; Wilson CM; Douglas SD; Futterman DC; Kingsley LA; Moscicki AB
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):959-63. PubMed ID: 10890357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnic and racial differences in long-term survival from hospitalization for HIV infection.
    Cunningham WE; Mosen DM; Morales LS; Andersen RM; Shapiro MF; Hays RD
    J Health Care Poor Underserved; 2000 May; 11(2):163-78. PubMed ID: 10793513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of race and gender with HIV-1 RNA levels and immunologic progression.
    Anastos K; Gange SJ; Lau B; Weiser B; Detels R; Giorgi JV; Margolick JB; Cohen M; Phair J; Melnick S; Rinaldo CR; Kovacs A; Levine A; Landesman S; Young M; Muñoz A; Greenblatt RM
    J Acquir Immune Defic Syndr; 2000 Jul; 24(3):218-26. PubMed ID: 10969345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers.
    Kassa E; Rinke de Wit TF; Hailu E; Girma M; Messele T; Mariam HG; Yohannes S; Jurriaans S; Yeneneh H; Coutinho RA; Fontanet AL
    AIDS; 1999 Feb; 13(3):381-9. PubMed ID: 10199229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vital Signs: HIV Infection, Diagnosis, Treatment, and Prevention Among Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2010-2019.
    Pitasi MA; Beer L; Cha S; Lyons SJ; Hernandez AL; Prejean J; Valleroy LA; Crim SM; Trujillo L; Hardman D; Painter EM; Petty J; Mermin JH; Daskalakis DC; Hall HI
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(48):1669-1675. PubMed ID: 34855721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women.
    Duncan R; Shapshak P; Page JB; Chiappelli F; McCoy CB; Messiah SE
    Front Biosci; 2007 Jan; 12():1488-95. PubMed ID: 17127396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in HIV-1 viral loads between male and female antiretroviral-untreated Mexican patients.
    Ballesteros-Zebadúa P; Villarreal C; Cocho G; Huerta L; Estrada JL
    Arch Med Res; 2013 May; 44(4):296-301. PubMed ID: 23608673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raltegravir pharmacokinetics in treatment-naive patients is not influenced by race: results from the raltegravir early therapy in African-Americans living with HIV (REAL) study.
    Wohl DA; Dumond JB; Blevins S; Pittard D; Ragan D; Wang R; Massengale K; Walsh K; Floris-Moore M; Eron JJ; Richardson A; Hudgens MG; Kashuba AD
    Antimicrob Agents Chemother; 2013 Feb; 57(2):784-8. PubMed ID: 23183440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention in HIV Care and Viral Suppression: Individual- and Neighborhood-Level Predictors of Racial/Ethnic Differences, Florida, 2015.
    Sheehan DM; Fennie KP; Mauck DE; Maddox LM; Lieb S; Trepka MJ
    AIDS Patient Care STDS; 2017 Apr; 31(4):167-175. PubMed ID: 28414260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zidovudine side effects as reported by black, Hispanic, and white/non-Hispanic patients with early HIV disease: combined analysis of two multicenter placebo-controlled trials.
    Jacobson MA; Gundacker H; Hughes M; Fischl M; Volberding P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):45-52. PubMed ID: 8528732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.
    Williams PL; Currier JS; Swindells S
    AIDS; 1999 Jun; 13(9):1035-44. PubMed ID: 10397533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.
    Wood E; Hogg RS; Yip B; Tyndall MW; Sherlock CH; Harrigan RP; O'Shaughnessy MV; Montaner JS
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):159-66. PubMed ID: 12045678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of gender and serum total cholesterol with CD4+ T cell count and HIV RNA load in antiretroviral-naïve individuals in Addis Ababa.
    Adal M; Howe R; Kassa D; Aseffa A; Petros B
    BMC Public Health; 2018 Jul; 18(1):943. PubMed ID: 30064395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.
    Enkhmaa B; Anuurad E; Zhang W; Abbuthalha A; Li XD; Dotterweich W; Pollard RB; Asmuth DM; Berglund L
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):387-92. PubMed ID: 23202367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in the use of drug therapy for HIV disease in an urban community.
    Moore RD; Stanton D; Gopalan R; Chaisson RE
    N Engl J Med; 1994 Mar; 330(11):763-8. PubMed ID: 8107743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.